About REMAP
Our team’s ultimate goal is to transform our clients’ relationship with their nervous system, allowing them to recreate, heal, and resolve their relationship with pain. Single-track investigation of chronic pain and inflammation is a dead-end. At REMAP, we use all the best evidence-informed tools to unlock the unique combination of life-factors that has lead to each client’s unique pain neurosignature, bringing lasting relief and REMAPPING at the core.
Change a person’s concept of pain and you change a person’s concept of themselves…
Change a person’s experience of pain and you change a person’s experience of themselves…
REMAP Vision for the Future of Pain Management
We foresee a world where chronic pain has been significantly reduced in prevalence, intensity, and duration. We see psychedelics being seamlessly incorporated with clinician and practitioner affiliated care, where both traditional compounds and next-gen formulations are used in rehabilitation and prophylactically to resolve and prevent chronic pain, in combination with a suite of interdisciplinary adjunctive therapies, individualized for each patient’s unique nervous system and disease progression. We see a vast network of affiliated professionals trained in REMAP’s framework and protocol, ready to apply this work in clinical practice and in the field..
The REMAP Story
REMAP Founder Court Wing is an accomplished performance and pain professional with 30+ years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injury to return to competition and daily life. He is a certified Z-Health Master Trainer, over 14 years of formal Ki-Aikido study, and was co-founder of NYC’s first CrossFit. Court is also a former chronic pain sufferer.
In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for Major Depressive Disorder. By the end of his “dosing” day, he was in full remission, no longer qualifying for the diagnosis of depression. More astounding were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. His commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain & performance, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain, and REMAP Therapeutics was born. In 2021, Court cofounded the non-profit, the Psychedelics & Pain Association.
REMAP Therapeutics is devoted to the development of formal psychedelic rehabilitation sessions and cohesive best practices for many treatment-resistant chronic pain conditions. Since it’s inception, REMAP has:
- Offered the first coursework available in this field of study: Integrating Neuromuscular Rehabilitation with Psychedelics
- Hosted the Psychedelics & Pain Symposium, annually since 2022, with top researchers from around the world, along with patient perspectives and practical workshops.
- Raised awareness and dialogue around psychedelics and chronic pain in various podcasts, forums, major media articles, and high-end conferences.
- Facilitated REMAP Retreats for clients in chronic pain seeking to find relief in combining neuromodulatory therapeutic approaches with psilocybin, helping them achieve striking remission and relief.
Was instrumental in the conception, organization, and authorship in publishing two groundbreaking case-studies in the field of study: - Cofounded the Psychedelics & Pain Association (PPA), with Bob Wold of Clusterbusters and Joe Moore of Psychedelics Today.
Court Wing
Founder & CEO
A former chronic pain sufferer, Court Wing is the Founder, CEO, & Lead Practitioner at REMAP Therapeutics. Court works closely with each REMAP client from start to finish, offering the best care in chronic pain treatment through the combined modalities of the REMAP Protocol.
Court is an accomplished performance and pain professional with over 14 years of formal Ki-Aikido study and 30 years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injury to return to competition and daily life. He is a certified Z-Health Master Trainer, was the co-founder of CrossFit NYC and has trained members of the FBI, NYPD, NYFD, NASA astronauts, pro-PGA golfers, Team Six Navy SEALs, UN diplomatic security, and former President of Estonia Toomas Hendrik Ilves. He has been interviewed in the NY Times Sunday Review, Men’s Fitness, USA Today, Whole Life Challenge, and other online features.
In March of 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for Major Depressive Disorder, sponsored by the Usona Institute. By the end of his “dosing” day in the trial, he was in full remission, no longer qualifying for the diagnosis of depression. More astounding were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. Court’s commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain & performance, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain and REMAP Therapeutics was born.
C.J. Spotswood
MSN, APRN, PMHNP-BC
C.J. Spotswood, MSN, APRN, PMHNP-BC aka “EntheoNurse” acts as REMAP’s Chief Psychiatric Clinician, completing all clients’ Pharmaceutical & Psychiatric Assessment to assess safety and efficacy of psychedelic use. These assessments provide an imperative review of all pharmaceuticals for drug-drug interactions and psychedelic dosage recommendations. All clients go through a comprehensive psychiatric evaluation ahead of beginning the REMAP Protocol, as well as receive education from C.J. on what to expect from psychedelic use. C.J. attends all in-person IMMERSIONS to provide harm reduction services.
BIO: C.J. is a board certified psychiatric-mental health nurse practitioner with over 20 years of psychiatric nursing experience. C.J. graduated from the University of Southern Maine completing his Psychiatric Mental Health Nurse Practitioner. C.J.’s undergraduate nursing degree (BSN) was from the University of Maine at Augusta, with a curriculum including yoga, Reiki, and various other complimentary and alternative modalities. C.J. is currently enrolled at California Institute of Integral Studies (CIIS) for their Psychedelic-Assisted Therapies and Research certificate program.
C.J. has been researching and teaching on psychedelics since 2018, which include having presented at the American Psychiatric Nurse Association’s National Conference on psychedelics in psychiatry, teaching master classes for Psychedelics Today’s Navigating Psychedelics: Clinicians & Therapists education program, co-authored Psychedelic.Support’s continuing education module on psilocybin, and is a past presenter at the Mt. Tam’s Psilocybin Summit.
C.J. is the author of “The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine”. C.J. presents an accredited continuing education program entitled “Psychedelics in Psychiatry for Nurses” on his personal website. C.J. is a member of OPENurss (Organization of Psychedelic and Entheogenic Nurses), the Psychedelic Medicine Association, and the American Psychiatric Nurse Association.
Dr. Joel Castellanos
Chief Science Advisor
Dr. Joel Castellanos, MD, Chief Science Advisor to REMAP, is a board-certified physical medicine and rehabilitation physician, fellowship-trained in pain and integrative medicine. Dr. Castellanos is a founding member and associate medical director of the Center for Psychedelic Research at UCSD and an associate professor in the Department of Anesthesiology at UCSD School of Medicine, where he instructs pain medicine fellows, as well as medical students, and residents in their pain rotations.
He completed his fellowship in pain medicine at UCSD School of Medicine and completed residency training in physical medicine and rehabilitation at the University of Michigan Medical School, where he also finished a two-year program in healthcare administration. Dr. Castellanos earned his medical degree from the University of Toledo College of Medicine.
He is an active member of numerous medical organizations including the American Academy of Pain Medicine, the American Academy of Physical Medicine and Rehabilitation, the International Association for the Study of Pain, and the North American Neuromodulation Society.
His landmark review paper on psychedelics and chronic pain has been foundational in REMAP’s mission of exploring, innovating, and developing the intersection between psychedelics and chronic pain. His recent publication, Chronic pain as an emergent property of a complex system and the potential role of psychedelics therapies is an excellent overview of the whole-body system in which pain presents.
Joe Moore
Principle Strategic Advisor
There are very few people who have been actively involved in the psychedelic space for as long as Joe Moore.
As a co-founder of Psychedelics Today, Joe has been at the forefront of psychedelic education. Alongside his personal and professional experience with psychedelics, Dreamshadow Transpersonal Breathwork, transpersonal psychology, trauma, and mental health, together with Psychedelics Today’s co-founder Kyle Buller, he has trained over 9,000 students and 400 clinicians into the art and science of psychedelic practice as a co-founder of Psychedelics Today.
Their VITAL certificate program is born out of their vast experience guiding, teaching, and leading the conversation on psychedelic therapy, as well as their mission to empower the future leaders of the psychedelic movement.
Joe began exploring psychedelics after discovering the work of transpersonal psychology founder Dr. Stanislav Grof when he was a philosophy student at Plymouth State University in 2001. Joe has been studying and practicing Grof’s Holotropic breathwork method at the Vermont-based Dreamshadow Group since 2003 and co-founded Boston Holotropic to facilitate breathwork workshops throughout New England.
Skilled in speaking, research, writing, and leadership, Joe founded Evolver Boston in 2008 and organized the Ayahuasca Monologues in Boston in 2011. He has facilitated legal psychedelic mushroom sessions in Jamaica, offers breathwork workshops in Breckenridge, Colorado, and is a board member of the nonprofit ‘Psychedelic Club’ which has chapters across the United States.
Joe has been an IT professional for 15 years and has supported capture software solutions for nearly a decade. He has extensive experience with product launches and cloud software.
An extreme athlete, Joe climbs, skis, snowboards, and skateboards. He has been scuba diving in Egypt’s Red Sea, Hawaii, Mexico, and Jamaica and is getting certified to sail in Colorado.
Our Team
Court Wing
Founder & CEO
View Bio
Dr. Joel Castellanos
CHIEF SCIENCE ADVISOR
View Bio
Joe Moore
PRINCIPLE STRATEGIC ADVISOR
View Bio
C.J. Spotswood
MSN, APRN, PMHNP-BC
View Bio
FAQs
The following FAQ’s are not mean to be an exhaustive list for all psychedelic or psilocybin related questions, rather they are tailored to the REMAP approach and questions we are most often asked by those seeking support for pain management through the use of psychedelic medicines. Please scroll down to the Resources section for links other relevant information, or reach out directly to our team for support.
Are REMAP Retreats legal? What is the legal status of psilocybin?
REMAP Retreats take place in Colorado, where Prop 122 has legalized the personal use of psilocybin and permits individuals and organizations, like REMAP, to provide “Harm Reduction Services” for those ingesting psychedelic substances. While Prop 122 does not allow the sale of psilocybin mushrooms or other natural medicines, it enables REMAP to support individuals and groups using psilocybin under the “personal use provision.” Within this framework, REMAP offers services focused on neuro-rehabilitation, psychiatric support, psychedelic preparation and integration, and comprehensive harm reduction guidance for healing, personal growth and exploration.
For more information, see here.
Who is present at REMAP IMMERSIONS?
- REMAP Founder & Lead Practitioner, Court Wing, as well as our principal Psychiatric Clinician, CJ Spotswood. Additionally, we are often joined by Magali Brecke, LAc MTCM, who both coordinates patient nutrition & lifestyle programs and co-facilitates during IMMERSIONS. We also have rotating, highly experienced, team members who are either facilitators, manual therapists, applied neurophysiology specialists, physiotherapy practitioners, or physiatrists.
- Group IMMERSIONS will include 5-7 participants at a time, in addition to the REMAP team.
- For One-on-One IMMERSIONS, clients may be joined by a trusted family member, friend, or member of their care team.
What are the risks of taking psychedelic medicine?
Considering risks is imperative when contemplating a psychedelic experience and it is equally important to recognize that psychedelic medicines are considered extremely safe when used in supportive contexts with proper preparation. Psychedelic risks are generally categorized into psychological risks and physiological risks.
Psychological risks can include anxiety, panic, paranoia, challenging emotional/spiritual experiences, depersonalization or derealization (see table). Psychedelics are considered “non-specific amplifiers”, meaning that they can amplify the current state of mind. For this reason, we strongly emphasize “set & setting.” “Set” refers to a participant’s mindset being in as neutral (ie. calm, stable) a space as possible. “Setting” refers to the surrounding environment being conducive and supportive to the malleable quality of a client’s psyche during and after a psychedelic session.
Physiological risks can include increased heart rate or blood pressure, or those risks associated with poor quality substances.
Common exclusionary criteria in modern psychedelic studies is having a first degree relative with bi-polar, psychosis, or schizophrenia. People with advanced cardiac conditions or high blood pressure are also excluded in modern studies, but these cautionary rules have been loosened in recent trials.
These rare, and often quite brief, challenges can occur. At REMAP, our highly trained team, including our experienced Psychiatric Nurse, C.J. Spotswood offers the best in harm reduction care beginning with the first client assessment.
Is there a possibility that my pain will get worse with psychedelic intervention?
As of this date, there is no evidence that psychedelics have caused anyone’s pain to grow worse permanently. A small percentage of participants in survey studies have reported an increase in their pain while psychedelics are acutely active (ie. during the “trip”) with a return to baseline after. Most reported an improvement in their psychological framework around their chronic pain and improvements in their sense of body agency. Some of those who experienced an acute increase also reported that they dosed in poor set & settings, i.e. during/after nighttime drinking, after difficult emotional experiences, and similar. To be clear, there are no published case reports of psychedelics worsening pain permanently or enduringly.
Will psychedelics “cure” my pain?
Chronic pain is complex, and for some, becomes an intractable condition. Psychedelics offer markedly new opportunities in pain management, with some individuals finding significant relief from their pain, either by taking these medicines in larger doses periodically, or daily in small doses. Many of these people have found total relief for weeks, months, or even years. Some experience little or no relief at all. For those for whom these medications work, the relief is often qualitatively different and stunning in its efficacy.
We are still in the early stages of investigation in this field of study, with active research and experimentation into identifying which compounds treat which conditions best, and for which patients.
Does REMAP offer scholarships?
We understand how impactful chronic pain can be on pain sufferers ability to earn a living wage. We currently do not offer scholarships but are looking to support them in the future with increases in our operating budget and philanthropic partnerships.
Do I have to stop taking my medications before coming on the retreat?
Most of our clients have complex presentations, often having been in the medical system for years, and as a result are prescribed multiple medications, aka “poly-pharma”. Even though you may have heard at other retreats “you have to completely taper off your meds”, we don’t recommend that or even think it’s necessary. There is a distinct cost-to-benfit ratio in withdrawing from multiple prescriptions and if mood destabilization and/or an increase in your pain baseline is the result, that may not be the most effective place to start reeducating your nervous system. Our principal psychiatric clinician is a psychiatric nurse practitioner with a 20+ year career. He is licensed to review and evaluate your medication schedule, analyze how they would interact with psychedelic medications, and then make recommendations in your medication schedule to coincide with your dosing days in order to get the best efficacy.
Your pre-retreat schedule is a lot more involved than other retreats; is that really necessary?
In order to give your individual nervous system the best opportunity to have improvements in your pain baselines, it’s necessary to identify sensorimotor deficits that can be contributing your total allostatic load, aka how much “threat” are you carrying, and perhaps more importantly, can you carry at any given time? Usually less once you develop chronic pain. Once key areas specific to your nervous system are identified, we then assess what kinds of neuromodulatory approaches you are most responsive to and then have you practice them, re-assess your response, and continue to make refinements. For these initial interventions to begin to “prime” your nervous system before the IMMERSION, there has to be enough volume and intensity developed ahead of time; usually around six weeks. Additionally, there is a significant amount of preparatory work in pain neurology educations, psychedelic mechanisms of action, and non-ordinary state of consciousness navigation. This is also a time for you to get to know the team and for us to get to become familiar with your unique “neurosignature” that will help us to identify and navigate around potential bottlenecks and roadblock in your process, while we developed a common movement, sensory, and orientation vocabulary to help us to work together on your journey. Our neuromodulatory approach is unique and groundbreaking in this field of study, requiring very specific preparation in order to give each client the best outcome available to them.
Your program is higher than other retreats I’ve seen listed online; how come?
As discussed in our previous question, we devote a lot of focus and client hours during our PREMAPPING period in order to maximize the benefits that emerge during our IMMERSION and REMAPPING segments. So that means more individual and group time specifically working with our specialists directly. If you were to book these services out independently, the total cost would be significantly higher than clients find in our programming.
I’ve discussed with my clinician/mental health provider that I’m planning on signing up for REMAP’s program and they have some questions & concerns; will you talk with them?
Absolutely; we understand and expect this response from your extended care team and our primary concern is making sure you have the best outcome possible. So a significant portion of that is making sure your health care providers understand our approach so that they can feel reassured regarding our procedures, the research involved that supports our practices, and getting informed on their before and after treatment for you. We want to make sure everyone is informed in order to provide a calm, stable program throughout your work with us.
I’ve heard mushrooms can make you throw-up and is considered “part of the process”; do I have to do that?
No, you don’t “have” to do that, and since we know many people with chronic pain have sensitive GI systems, we don’t want to add further distress to an already overtaxed nervous system, so we take steps to mitigate those potential nausea inducting effects. That being said, mushrooms and other psychedelic-containing substances are often interacting with serotonin receptors directly in the gut, responsible for smooth muscle contractions among other activities, aka the same musculature responsible for inducing vomiting. Not everyone does, but it can happen. Plus, the cell-wall structure of mushrooms isn’t readily digestible, so that can contribute as well. In our work, we have specific recommendations for preparation and ingestion of the mushrooms in a manner to minimize this from occurring, as well as have medications available to settle your stomach as necessary. In the end, most people don’t have significant gastric disturbance from mushrooms and even if they do experience some, often consider it a small nuisance in comparison to the overwhelming benefit of these medicinal compounds.